It's part of their expertise... The excitement of last June was true for several OTC stocks, some of which have larger OS than IPIX and at that time printed between 1-4 Billion in market cap.
Anyone who thinks this cannot happen here upon good interim results from the upcoming clinical trial, is simply mistaken, imo.
Yes, Duchamp, hard to stay positive and realistic, hoping these are not contradictory terms. Happy I got me last bit of shares at .165, still wondering if my incessant buying at lows is wise, or not. Either way, the leverage is still here